ENTITY
OrbusNeich Medical Group Holdings

OrbusNeich Medical Group Holdings (6929 HK)

5
Analysis
Health CareHong Kong
OrbusNeich Medical Group Holdings Limited operates as a medical device manufacturer. The Company develops, manufactures, and distributes interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. OrbusNeich Medical Group Holdings markets its products in Asia, Europe, America, and other countries and regions.
more
bullishUBTech Robotics
18 Feb 2024 11:00

HSCI Index Rebalance: 25 Adds, 29 Deletes & Changes to Southbound Stock Connect

There are 25 adds and 29 deletes for the HSCI in March. 21 stocks will be added to Stock Connect while 27 will be deleted. Positions via the...

Logo
723 Views
Share
25 Feb 2023 16:00

HSCI Index Rebalance: 35 Adds, 28 Deletes & Changes to Southbound Stock Connect

There are 35 adds & 28 deletes for the HSCI in March leading to 29 adds & 20 deletes for Stock Connect. 19 index constituents could be dropped from...

Logo
639 Views
Share
07 Dec 2022 19:17

Pre-IPO OrbusNeich Medical Group: Large Global Exposure Protects from Negative Price Effect in China

OrbusNeich is expected to price its IPO on Dec 16 and debut on HK market before Christmas. The company intends to use IPO proceeds to develop and...

Logo
369 Views
Share
02 Jun 2022 08:28

Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns

The rich pipeline and large global business will help OrbusNeich “hedge” negative domestic policy impact. But fierce competition, slow progress in...

Logo
491 Views
Share
24 Jan 2022 17:00

Pre-IPO OrbusNeich Medical Group: A Scale Player, With Comprehensive Portfolio in PCI Balloon Market

This insight has analyzed the product offerings, strength, and weakness of OrbusNeich Medical Group ahead of its IPO. The company intends to raise...

Logo
347 Views
Share
No more insights
x